These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 32993587

  • 1. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
    Bilguun EO, Kaira K, Kawabata-Iwakawa R, Rokudai S, Shimizu K, Yokobori T, Oyama T, Shirabe K, Nishiyama M.
    BMC Cancer; 2020 Sep 29; 20(1):935. PubMed ID: 32993587
    [Abstract] [Full Text] [Related]

  • 2. STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.
    Otaka Y, Rokudai S, Kaira K, Fujieda M, Horikoshi I, Iwakawa-Kawabata R, Yoshiyama S, Yokobori T, Ohtaki Y, Shimizu K, Oyama T, Tamura J, Prives C, Nishiyama M.
    Clin Cancer Res; 2017 Jul 01; 23(13):3442-3452. PubMed ID: 28087642
    [Abstract] [Full Text] [Related]

  • 3. STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.
    Rokudai S, Li Y, Otaka Y, Fujieda M, Owens DM, Christiano AM, Nishiyama M, Prives C.
    Proc Natl Acad Sci U S A; 2018 May 22; 115(21):E4806-E4814. PubMed ID: 29735662
    [Abstract] [Full Text] [Related]

  • 4. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z, Zhang H, Lian M, Yue C, Dong G, Jin Y, Li R, Wan H, Wang R, Wang Y, Zhai J, Ma H, Feng L, Han J, Liu S, Guo Y, Li J, Liu Y, Fang J, Liu H.
    Oncol Rep; 2017 Nov 22; 38(5):3019-3029. PubMed ID: 29048627
    [Abstract] [Full Text] [Related]

  • 5. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.
    Ann Surg Oncol; 2017 Dec 22; 24(13):4017-4024. PubMed ID: 28933054
    [Abstract] [Full Text] [Related]

  • 6. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
    Cui Y, Cui CA, Yang ZT, Ni WD, Jin Y, Xuan YH.
    Exp Mol Pathol; 2017 Apr 22; 102(2):347-353. PubMed ID: 28286162
    [Abstract] [Full Text] [Related]

  • 7. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN, Liu Y, Meng Q, Li X, Wang F, Yao G, Wang L, Fu S, Tong D.
    Med Oncol; 2015 Feb 22; 32(2):459. PubMed ID: 25588924
    [Abstract] [Full Text] [Related]

  • 8. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
    Zhang Y, Wang Y, Yin X, Huang Y.
    Sci Rep; 2022 Jul 01; 12(1):11206. PubMed ID: 35778526
    [Abstract] [Full Text] [Related]

  • 9. Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
    Qin S, Long X, Zhao Q, Zhao W.
    Cancer Invest; 2020 Jan 01; 38(1):13-22. PubMed ID: 31770041
    [Abstract] [Full Text] [Related]

  • 10. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
    Shin SJ, Jeon YK, Cho YM, Lee JL, Chung DH, Park JY, Go H.
    Oncologist; 2015 Nov 01; 20(11):1253-60. PubMed ID: 26424759
    [Abstract] [Full Text] [Related]

  • 11. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
    Xu J, Yang S, Gu X, Shen H, Wang L, Xu W, Fang L, Mao Y, Xu L, Chen Y, Fan W, Wang J.
    Exp Mol Pathol; 2019 Oct 01; 110():104276. PubMed ID: 31233732
    [Abstract] [Full Text] [Related]

  • 12. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
    Ma H, Tong L, Zhang Q, Chang W, Li F.
    Biomed Res Int; 2020 Oct 01; 2020():6427483. PubMed ID: 32596344
    [Abstract] [Full Text] [Related]

  • 13. Stathmin guides personalized therapy in oral squamous cell carcinoma.
    Ju WT, Ma HL, Zhao TC, Liang SY, Zhu DW, Wang LZ, Li J, Zhang ZY, Zhou G, Zhong LP.
    Cancer Sci; 2020 Apr 01; 111(4):1303-1313. PubMed ID: 31994271
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R, Guo Y, Ma H, Feng L, Wang Q, Chen X, Lian M, Wang H, Fang J.
    Tumour Biol; 2016 Feb 01; 37(2):2635-45. PubMed ID: 26395262
    [Abstract] [Full Text] [Related]

  • 15. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
    Giotakis AI, Lazaris AC, Kataki A, Kontos CK, Giotakis EI.
    Cancer Biomark; 2019 Feb 01; 25(2):141-149. PubMed ID: 31104007
    [Abstract] [Full Text] [Related]

  • 16. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
    Gao X, Wang Y, Zhao H, Wei F, Zhang X, Su Y, Wang C, Li H, Ren X.
    Oncotarget; 2016 Sep 13; 7(37):59664-59675. PubMed ID: 27517633
    [Abstract] [Full Text] [Related]

  • 17. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M, Kaneda H, Tanizaki J, Sakai K, Togashi Y, Terashima M, De Velasco MA, Fujita Y, Banno E, Nakamura Y, Takeda M, Ito A, Mitsudomi T, Nakagawa K, Okamoto I, Nishio K.
    Cancer Sci; 2016 Nov 13; 107(11):1667-1676. PubMed ID: 27581340
    [Abstract] [Full Text] [Related]

  • 18. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI, Kontos CK, Manolopoulos LD, Sismanis A, Konstadoulakis MM, Scorilas A.
    Clin Biochem; 2016 Aug 13; 49(12):890-6. PubMed ID: 27129795
    [Abstract] [Full Text] [Related]

  • 19. Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation.
    Li Y, Peart MJ, Prives C.
    Mol Cell Biol; 2009 Jul 13; 29(14):3953-63. PubMed ID: 19451233
    [Abstract] [Full Text] [Related]

  • 20. A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
    Li S, Teng Y, Yuan MJ, Ma TT, Ma J, Gao XJ.
    Biomark Med; 2020 Jan 13; 14(1):53-63. PubMed ID: 31729251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.